Literature DB >> 23254384

Emergence of late-onset placental dysfunction: relationship to the change in uterine artery blood flow resistance between the first and third trimesters.

Elisa Llurba1, Ozhan Turan, Tania Kasdaglis, Chris R Harman, Ahmet A Baschat.   

Abstract

OBJECTIVES: To test if emergence of third-trimester (T3) placental dysfunction is related to the impedance change in uterine artery blood flow resistance between the first trimester (T1) and T3. STUDY
DESIGN: Mean T1 and T3 uterine artery (mUtA) pulsatility index (PI) was measured in 1098 singletons. Each patient's individual mUtA-PI change was calculated ([(T3 PI - T1 PI/interval in days)] × 100; ΔmUtA-PI). This parameter and T1 and T3 mUtA-PI z-scores were related to placenta-related disease (PRD) and to constitutionally small neonates (CS).
RESULTS: Forty-seven (5%) women had PRD and 83 (8.7%) delivered a CS neonate. T1 and T3 mUtA-PI z-scores were higher with PRD (0.418 versus -0.097 and 1.06 versus -0.13, p < 0.001 for all). Change in mUtA-PI (ΔmUtA PI) was similar for patients with PRD. However, the prevalence of PRD doubled with rising ΔmUtA-PI (11.1% versus 5.2%, p = 0.041).
CONCLUSION: T3 uterine artery Doppler performs significantly better in detecting patients at risk for late-onset PRD than T1 or the gestational age change in uterine artery Doppler resistance This suggests that a proportion of late emerging PRD is not amenable to early screening by uterine artery Doppler. Further research is essential to identify the optimal screening strategy for late-onset placental dysfunction. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2012        PMID: 23254384     DOI: 10.1055/s-0032-1329181

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  7 in total

Review 1.  Advanced MR imaging of the placenta: Exploring the in utero placenta-brain connection.

Authors:  Nickie Niforatos Andescavage; Adre du Plessis; Catherine Limperopoulos
Journal:  Semin Perinatol       Date:  2015-03-09       Impact factor: 3.300

2.  Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study.

Authors:  M López; M Palacio; A Goncé; S Hernàndez; F J Barranco; L García; M Loncà; J O Coll; E Gratacós; F Figueras
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-09       Impact factor: 3.267

Review 3.  A Review of Roles of Uterine Artery Doppler in Pregnancy Complications.

Authors:  Yingying Tian; Xiuhua Yang
Journal:  Front Med (Lausanne)       Date:  2022-03-03

4.  Value of Cerebroplacental Ratio and Uterine Artery Doppler as Predictors of Adverse Perinatal Outcome in Very Small for Gestational Age at Term Fetuses.

Authors:  Anne Karge; Silvia M Lobmaier; Bernhard Haller; Bettina Kuschel; Javier U Ortiz
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

5.  Independent influences of maternal obesity and fetal sex on maternal cardiovascular adaptation to pregnancy: a prospective cohort study.

Authors:  Noor E W D Teulings; Angela M Wood; Ulla Sovio; Susan E Ozanne; Gordon C S Smith; Catherine E Aiken
Journal:  Int J Obes (Lond)       Date:  2020-06-15       Impact factor: 5.095

6.  Association of second trimester uterine artery Doppler parameters with maternal hypertension 2-7 years after delivery.

Authors:  Eliza C Miller; Benjamin Carper; Natalie A Bello; C Noel Bairey Merz; Philip Greenland; Lisa D Levine; David M Haas; William A Grobman; Rebecca B McNeil; Judith H Chung; Jennifer Jolley; George R Saade; Robert M Silver; Hyagriv N Simhan; Ronald J Wapner; Corette B Parker
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2021-08-12

7.  B-flow/spatiotemporal image correlation M-mode: novel ultrasound method that detects decrease in spiral artery luminal diameter in first trimester in primate model of impaired spiral artery remodeling.

Authors:  O M Turan; J S Babischkin; G W Aberdeen; S Turan; C R Harman; G J Pepe; E D Albrecht
Journal:  Ultrasound Obstet Gynecol       Date:  2022-03       Impact factor: 8.678

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.